Skip to content

Clinical trials

Phase 2 Carcinoma, Merkel Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Merkel Cell Phase: Phase 2 Country / region: Australia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20191
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
EMD Serono Research & Development Institute, Inc.1
ImaginAb, Inc.1
Incyte Corporation1
Melanoma Institute Australia1
Melanoma and Skin Cancer Trials Limited1
Regeneron Pharmaceuticals1
Trans Tasman Radiation Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Merkel Cell7
Carcinoma, Non-Small-Cell Lung2
Basal Cell Carcinoma1
Carcinoma, Renal Cell1
Cutaneous Squamous Cell Carcinoma1
Melanoma1
Neoplasm Metastasis1
Neuroendocrine Tumors1
Squamous Cell Carcinoma of Head and Neck1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.